Latest current cash for CYTHW: $930K.
Get informed when a big investor buys or sells
+ FollowLatest change versus the prior comparable period (same company).
Cyclo Therapeutics- Warrants (14/11/2025) (CYTHW) currently reports a current cash of $930K as of September 2024. That compares with $1.8M in the prior-year period — down 48.5% year over year. Use the charts on this page to explore Cyclo Therapeutics- Warrants (14/11/2025)'s current cash history and peer comparisons.
Cyclo Therapeutics- Warrants (14/11/2025)'s current cash decreased from $1.8M to $930K — a 48.5% year-over-year decrease (period ending September 2024). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.
Cyclo Therapeutics- Warrants (14/11/2025) reported $930K in current cash as of September 2024. That compares with $1.8M in the prior-year period — down 48.5% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.
Start with the current current cash of $930K, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Cyclo Therapeutics- Warrants (14/11/2025), and consider following CYTHW for alerts when major investors trade the stock.
Cyclo Therapeutics- Warrants (14/11/2025) is classified in the Healthcare sector. On current cash, it currently shows $930K. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing CYTHW with unrelated industries.